Pfizer (PFE)
25.69
+0.35 (1.38%)
Upcoming Events
Latest Headlines
ADA 2026 preview: All eyes on these 2 stocks
June 4, 2026 7:00 PM - StreetInsider
Form 4 PFIZER INC For: May 29 Filed by: BOURLA ALBERT
June 1, 2026 7:42 PM - SEC Filing
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
June 1, 2026 10:00 AM - BizWire
Lilly’s Cancer Bombshell Sparks Hunt for the Next Oncology Stock Set to Explode
June 1, 2026 9:05 AM - StreetInsider
Pfizer (PFE) Reiterates at Neutral by Cantor Fitzgerald
June 1, 2026 8:02 AM - StreetInsider
Pfizer drug combination cuts prostate cancer progression risk by 52%
June 1, 2026 2:54 AM - StreetInsider
Pfizer's BRAFTOVI regimen shows improved survival in colorectal cancer
June 1, 2026 2:53 AM - StreetInsider
Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
May 31, 2026 8:00 AM - BizWire
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
May 30, 2026 8:00 AM - BizWire
Morgan Stanley: China healthcare sector dips 1.3% amid licensing scrutiny
May 29, 2026 12:07 PM - StreetInsider
Pfizer's LORBRENA shows 55% seven-year survival without progression
May 29, 2026 8:02 AM - StreetInsider
Seven-Year Analysis from Pfizer’s LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer
May 29, 2026 8:00 AM - BizWire
Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
May 28, 2026 7:00 PM - PR NewsWire
Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
May 28, 2026 7:00 PM - BizWire
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
May 27, 2026 10:00 AM - BizWire
UBS Reiterates Neutral Rating on Pfizer (PFE)
May 27, 2026 9:46 AM - StreetInsider
Pfizer starts phase 3 trial for pediatric pneumococcal vaccine
May 20, 2026 5:05 AM - StreetInsider
Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results
May 20, 2026 5:05 AM - BizWire
Form 4 PFIZER INC For: May 15 Filed by: BOURLA ALBERT
May 18, 2026 4:39 PM - SEC Filing
Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026
May 18, 2026 8:01 AM - PR NewsWire
Arvinas Inc. (ARVN) PT Raised to $16 at BofA Securities
May 13, 2026 2:53 PM - StreetInsider
European Commission approves Pfizer's HYMPAVZI for hemophilia with inhibitors
May 13, 2026 6:45 AM - StreetInsider
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors
May 13, 2026 6:45 AM - BizWire
Form 13F-HR PFIZER INC For: Mar 31
May 12, 2026 4:52 PM - SEC Filing
FDA Commissioner Marty Makary to step down - Politico
May 12, 2026 12:52 PM - StreetInsider
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
May 12, 2026 9:00 AM - StreetInsider
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
May 12, 2026 7:01 AM - StreetInsider
Arvinas and Pfizer sell VEPPANU rights to Rigel for $85 million upfront
May 12, 2026 7:01 AM - StreetInsider
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
May 12, 2026 7:00 AM - Globe NewsWire
MBX Biosciences (MBX) PT Raised to $86 at Citizens on 'Good' MBX 4291 Update
May 12, 2026 5:37 AM - StreetInsider
HHS downplays Hantavirus risk amid repatriation efforts
May 11, 2026 10:23 AM - StreetInsider
The Next Generation of the GLP-1 Revolution Is Already Underway
May 11, 2026 8:30 AM - Globe NewsWire
Health officials explore restrictions on certain SSRI antidepressants - Reuters
May 8, 2026 12:04 PM - StreetInsider
Novo Nordisk Eyes Large-Scale M&A Following Pfizer's Metsera Win - Semafor
May 7, 2026 2:15 PM - StreetInsider
Form S-8 PFIZER INC
May 5, 2026 4:42 PM - SEC Filing
Pfizer (PFE) PT Raised to $27 at BofA Securities
May 5, 2026 3:11 PM - StreetInsider
Pfizer Reviewing New Molecule It Designed Using AI - CEO
May 5, 2026 2:11 PM - StreetInsider
Pfizer beats first quarter estimates on strong product growth
May 5, 2026 7:17 AM - StreetInsider
Form 10-Q PFIZER INC For: Mar 29
May 5, 2026 7:03 AM - SEC Filing
Form 8-K PFIZER INC For: May 05
May 5, 2026 7:01 AM - SEC Filing
Pfizer (PFE) Tops Q1 EPS by 3c, Beats on Revenue; Offers FY26 EPS Guidance
May 5, 2026 6:46 AM - StreetInsider
Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance
May 5, 2026 6:45 AM - BizWire
Form 4 PFIZER INC For: Apr 30 Filed by: BOURLA ALBERT
May 4, 2026 4:20 PM - SEC Filing
Pfizer (PFE) call put ratio 4.7 calls to 1 put quarter results
May 4, 2026 11:18 AM - StreetInsider
Pfizer (PFE) calls more active than puts into quarter results
May 4, 2026 5:38 AM - StreetInsider
FDA approves first PROTAC therapy VEPPANU for breast cancer
May 1, 2026 12:43 PM - StreetInsider
Form SCHEDULE 13G PFIZER INC Filed by: VANGUARD CAPITAL MANAGEMENT LLC
May 1, 2026 11:53 AM - SEC Filing
Pfizer (PFE) call put ratio 2.9 calls to 1 put with a focus on May 8 weekly 27 calls into quarter results
May 1, 2026 10:50 AM - StreetInsider
Pfizer's ELREXFIO meets primary endpoint in multiple myeloma trial
April 29, 2026 6:45 AM - StreetInsider
Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma
April 29, 2026 6:45 AM - BizWire
Raymond James on BridgeBio Pharma (BBIO): 'We expect continued strong commercial momentum for Attruby'
April 28, 2026 2:00 PM - StreetInsider
Barclays on BridgeBio Pharma (BBIO): 'We see buying opportunity on weakness, reiterate top idea'
April 28, 2026 12:14 PM - StreetInsider
TD Cowen on BridgeBio Pharma (BBIO): 'A key overhang is removed now'
April 28, 2026 11:46 AM - StreetInsider
RBC Capital on BridgeBio Pharma (BBIO): 'we remain buyers'
April 28, 2026 11:41 AM - StreetInsider
Mizuho on BridgeBio Pharma (BBIO): 'Not Best Case but Still Good Outcome Relative to Street'
April 28, 2026 11:25 AM - StreetInsider
Morgan Stanley on Pfizer (PFE): 'we believe generic versions of Vyndaqel could still represent a potential headwind to the franchise'
April 28, 2026 10:53 AM - StreetInsider
Pfizer extends VYNDAMAX patent protection to 2031 through settlements
April 28, 2026 10:17 AM - StreetInsider
Pfizer Reaches Three Settlement Agreements for VYNDAMAX
April 28, 2026 10:17 AM - BizWire
Mizuho: 'BBIO could potentially trade in the $90-110+ range today / near-term'
April 28, 2026 9:48 AM - StreetInsider
RBC on Pfizer (PFE): 'Litigation overhang cleared'
April 28, 2026 9:46 AM - StreetInsider
Barclays: 'We think dropping the question of '441 validity from the case is a major development'
April 28, 2026 9:38 AM - StreetInsider
Form 4 PFIZER INC For: Apr 23 Filed by: LITTMAN DAN R.
April 27, 2026 6:40 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: Gottlieb Scott
April 27, 2026 6:40 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: NORA JOHNSON SUZANNE M
April 27, 2026 6:40 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: Desmond-Hellmann Susan
April 27, 2026 6:38 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: BLAYLOCK RONALD E
April 27, 2026 6:38 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: Buckley Mortimer J
April 27, 2026 6:38 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: Echevarria Joseph
April 27, 2026 6:38 PM - SEC Filing
Form 3/A PFIZER INC For: Apr 01 Filed by: Hancock Dennis P
April 27, 2026 6:24 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: NARAYEN SHANTANU
April 27, 2026 6:24 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: SMITH JAMES C
April 27, 2026 6:22 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: Quincey James
April 27, 2026 6:22 PM - SEC Filing
Form 4 PFIZER INC For: Apr 23 Filed by: Taraporevala Cyrus
April 27, 2026 6:22 PM - SEC Filing
Form 8-K PFIZER INC For: Apr 23
April 27, 2026 5:18 PM - SEC Filing
Bristol Myers Squibb and Pfizer partner with Mark Cuban's Cost Plus Drugs
April 24, 2026 6:59 AM - StreetInsider
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
April 24, 2026 6:59 AM - BizWire
Pfizer Declares Second-Quarter 2026 Dividend
April 22, 2026 4:45 PM - BizWire
Pfizer (PFE) Declares $0.43 Quarterly Dividend; 6.4% Yield
April 22, 2026 4:45 PM - StreetInsider
Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026
April 21, 2026 11:51 AM - BizWire
FDA grants priority review to Astellas-Pfizer cancer drug application
April 20, 2026 6:45 AM - StreetInsider
U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
April 20, 2026 6:45 AM - PR NewsWire
Form 4 PFIZER INC For: Apr 15 Filed by: BOURLA ALBERT
April 17, 2026 1:17 PM - SEC Filing
Form 4 PFIZER INC For: Apr 14 Filed by: BOURLA ALBERT
April 16, 2026 4:31 PM - SEC Filing
CICC Starts Pfizer (PFE) at Outperform
April 15, 2026 6:14 AM - StreetInsider
Pfizer (PFE) PT Raised to $27 at UBS
April 13, 2026 8:55 AM - StreetInsider
Pfizer (PFE) PT Raised to $34 at BMO Capital
April 13, 2026 7:59 AM - StreetInsider
Guggenheim Reiterates Buy Rating on Pfizer (PFE)
April 13, 2026 6:58 AM - StreetInsider
Form 3 PFIZER INC For: Apr 01 Filed by: Hancock Dennis P
April 10, 2026 1:11 PM - SEC Filing
Pfizer (PFE) PT Raised to $28 at Morgan Stanley
April 10, 2026 8:16 AM - StreetInsider
Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders
April 9, 2026 10:00 AM - BizWire
Pfizer (PFE) PT Lowered to $26 at BofA Securities
April 9, 2026 9:24 AM - StreetInsider
Telix Strengthens Board with Additional Director Appointments
April 8, 2026 6:44 PM - Globe NewsWire
AI-Enhanced Robotics in Pharma Manufacturing Signals Major Efficiency, Margin Expansion Opportunities
April 7, 2026 12:49 PM - Globe NewsWire
RBC Capital Reiterates Underperform Rating on Pfizer (PFE)
April 7, 2026 8:54 AM - StreetInsider
AI-Enhanced Robotics in Pharma Manufacturing Signals Major Efficiency, Margin Expansion Opportunities
April 7, 2026 8:41 AM - StreetInsider
Form 4 PFIZER INC For: Mar 31 Filed by: BOURLA ALBERT
April 1, 2026 5:53 PM - SEC Filing
Leerink Partners on Pfizer (PFE): 'positive ruling today should drive additional Comirnaty OUS sales'
April 1, 2026 3:01 PM - StreetInsider
Exclusive-Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles
April 1, 2026 12:16 PM - StreetInsider
Pfizer (PFE) to shutter South S.F. research site, end Bay Area presence - Bloomberg
March 31, 2026 1:10 PM - StreetInsider
Wolfe: 'We're observing some reports of GLP-1 users refreshing their wardrobes as weight loss progresses'
March 31, 2026 6:35 AM - StreetInsider
Form 4 PFIZER INC For: Mar 27 Filed by: Taraporevala Cyrus
March 30, 2026 8:22 PM - SEC Filing
Form 4 PFIZER INC For: Mar 27 Filed by: SMITH JAMES C
March 30, 2026 8:21 PM - SEC Filing
Form 4 PFIZER INC For: Mar 27 Filed by: Quincey James
March 30, 2026 8:20 PM - SEC Filing
Form 4 PFIZER INC For: Mar 27 Filed by: Echevarria Joseph
March 30, 2026 8:19 PM - SEC Filing
Form 4 PFIZER INC For: Mar 27 Filed by: NARAYEN SHANTANU
March 30, 2026 8:19 PM - SEC Filing
Form 4 PFIZER INC For: Mar 27 Filed by: Buckley Mortimer J
March 30, 2026 8:18 PM - SEC Filing
Form SCHEDULE 13G/A PFIZER INC Filed by: VANGUARD GROUP INC
March 27, 2026 11:23 AM - SEC Filing
Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts
March 24, 2026 10:00 AM - BizWire
Pfizer (PFE) PT Raised to $36 at Guggenheim
March 24, 2026 6:30 AM - StreetInsider
Pfizer and Valneva's Lyme disease vaccine shows over 70% efficacy
March 23, 2026 6:45 AM - StreetInsider
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
March 23, 2026 6:45 AM - BizWire
Pfizer advises shareholders to reject Tutanota mini-tender offer
March 20, 2026 4:30 PM - StreetInsider
Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC
March 20, 2026 4:30 PM - BizWire
Pfizer's TALZENNA combination shows progress against prostate cancer
March 19, 2026 6:45 AM - StreetInsider
TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
March 19, 2026 6:45 AM - BizWire
Morgan Stanley on Pfizer (PFE): Atirmo Ph2 data an 'incremental positive'
March 17, 2026 8:39 AM - StreetInsider
Pfizer drug shows 40% reduction in breast cancer progression risk
March 17, 2026 6:45 AM - StreetInsider
Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer
March 17, 2026 6:45 AM - BizWire
Stocks expected to have increasing option volume: LMND MRNA PFE BNTX NVAX AZN BMY LLY GSK JNJ MRK NVS MRK SNY
March 17, 2026 5:42 AM - StreetInsider
Pfizer (PFE) PT Raised to $32 at HSBC
March 17, 2026 3:39 AM - StreetInsider
Form 4 PFIZER INC For: Mar 13 Filed by: BOURLA ALBERT
March 16, 2026 5:46 PM - SEC Filing
US Judge blocks Trump Admin cuts to number of routinely recommended vaccines for children - Reuters
March 16, 2026 3:46 PM - StreetInsider
Form ARS PFIZER INC For: Dec 31
March 12, 2026 9:20 AM - SEC Filing
Form DEFA14A PFIZER INC
March 12, 2026 9:13 AM - SEC Filing
Form DEF 14A PFIZER INC For: Apr 23
March 12, 2026 9:08 AM - SEC Filing
US vaccine advisers drop plan to question mRNA COVID shots, WaPo reports
March 11, 2026 6:32 AM - StreetInsider
BMO Capital Reiterates Outperform Rating on Pfizer (PFE) following Ph2 data
March 9, 2026 11:51 AM - StreetInsider
FDA: 'The agency today is withdrawing final guidance titled “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product'
March 9, 2026 10:53 AM - StreetInsider
Pfizer's trispecific antibody shows positive results in atopic dermatitis
March 9, 2026 6:45 AM - StreetInsider
Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis
March 9, 2026 6:45 AM - BizWire
Full Article List
